Evidence map›Paper›PMID 41210208›Full record

ArticleInternational journal of general medicine2025

Diagnostic Value of Homocysteine Metabolic Pathway in Coronary Atherosclerosis: A Study on Reference Intervals and Risk Prediction.

Shen Li, Furong Zhao, Mo Hong, Yanru Zhu, Hongzhi Sun

Abstract read
In one paragraph

Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shen LiCentral Laboratory, Central Hospital of Dalian University of Technology, Dalian, People's Republic of China.
Furong ZhaoLiaoning Provincial Key Laboratory of Clinical Oncology Metabonomics, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, People's Republic of China.
Mo HongDalian Boyuan Medical Technology Co. Ltd, Dalian, People's Republic of China.
Yanru ZhuDalian Boyuan Medical Technology Co. Ltd, Dalian, People's Republic of China.
Hongzhi SunLiaoning Provincial Key Laboratory of Clinical Oncology Metabonomics, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, People's Republic of China.ORCID 0009-0004-4484-4843

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To determine the reference intervals of homocysteine (Hcy) metabolic pathway in healthy adults using direct continuous sampling, and to explore their correlations with coronary atherosclerosis (CA) for improving the risk assessment and diagnostic accuracy of CA. Patients and Methods: A total of 426 reference individuals were selected via direct continuous sampling of the two centers from healthy adults based on questionnaires and laboratory indicators. Additionally, 75 patients were diagnosed with CA by cardiologists. Standardized analysis of Hcy, cysteine (Cys) and methionine (Met) levels in serum were conducted using commercial assay kits compatible with LC-MS/MS. Results: Although Met and Hcy showed significant differences between the sexes, they could not meet the criteria for setting reference intervals. After outlier removal and normality conversion, 95% reference intervals of Hcy, Cys and Met were calculated as 7-25 μmol/L, 227-410 μmol/L, and 21-39 μmol/L, respectively. In addition, the correlations among Hcy, Cys, and Met were influenced by CA, and each served as an independent risk factor. The area under the curve (AUC) for the combined three indicators increased to 0.86 (95% CI: 0.81-0.91). The specificity increased to 83%, while the sensitivity reached 78%. Conclusion: The Hcy metabolic pathway significantly enhances risk assessment capability and may be helpful in providing reference values for the diagnosis and risk prediction of CA.

Indexed as

coronary atherosclerosiscysteinehomocysteinemethioninereference intervalsrisk assessment

Identifiers

PMID41210208
PMCPMC12595925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.